避妊薬市場：製品別、年齢層別、薬剤クラス別、処方形態別、流通別、投与経路別-2025-2030年世界予測

避妊薬市場は、2023年に195億3,000万米ドルと評価され、2024年には207億6,000万米ドルに達すると予測され、CAGR 6.46％で成長し、2030年には302億7,000万米ドルに達すると予測されています。

避妊薬市場は、排卵を抑制するホルモン製剤を通じて妊娠を予防する役割によって定義されます。エストロゲンとプロゲスチンの複合型経口避妊薬やプロゲスチンのみのピルなど様々なタイプがあり、主に生殖年齢層の女性を対象としています。避妊薬の必要性は、家族計画に対する意識の高まり、効果的な妊娠予防法の必要性、そして生殖を選択する女性のエンパワーメントからきています。これらのピルは避妊だけでなく、月経障害、にきび、子宮内膜症の管理にも用途が見出され、最終用途の範囲は多様な層に広がっています。市場の成長は、教育水準の向上、ヘルスケアへのアクセスの増加、避妊対策に対する政府の支援の高まりに大きく影響されています。最近の低用量ピルの進歩や長期周期ピルのイントロダクションは、市場拡大の潜在的機会を提示しています。こうした機会を活用するため、企業は手頃な価格の強化、流通チャネルの拡大、教育キャンペーンによる認知度向上に注力すべきです。しかし、副作用リスクの認識、倫理的・宗教的反対、規制上の制約などの課題が、市場拡大の妨げになる可能性があります。さらに、文化的偏見や認識不足により、市場浸透が限定的な地域もあります。この分野の技術革新は、非ホルモンピルの開発、個別化医療アプローチ、服薬アドヒアランス向上と追跡のためのデジタルヘルスソリューションの分野で熟しています。これらのイノベーションは、ヘルスケアプロバイダーとの戦略的パートナーシップとともに、事業の成長を促進することができます。市場は断片的ではあるがダイナミックな性質を示し、M&Aによる統合の可能性を示しています。全体として、進化するニーズと認知に対応し、研究開発に投資し、パーソナライズされた体験に注力することが、競争は激しいが有望なこの市場で成長を獲得するために極めて重要です。

市場力学：急速に進化する避妊薬市場の主要市場インサイトを公開

避妊薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 意図しない妊娠を防ぐための避妊薬の使用増加と家族計画に対する意識の高まり
  • 性感染症（STD）の流行の高まり
  • 避妊薬の使用を奨励する政府の支援策
• 市場抑制要因
  • 避妊薬による製品回収の発生と健康への悪影響
• 市場機会
  • 避妊用ピルの処方およびパッケージングの先進化
  • オンラインチャネルを通じた避妊薬の入手可能性
• 市場の課題
  • ピル使用に関する安全性と社会的懸念、製品マーケティングに関する問題

ポーターのファイブフォース：避妊薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：避妊薬市場における外部からの影響の把握

外部マクロ環境要因は、避妊薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析避妊薬市場における競合情勢の把握

避妊薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス避妊薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、避妊薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨避妊薬市場における成功への道筋を描く

避妊薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 望まない妊娠を防ぐための避妊薬の使用増加と家族計画に関する意識の高まり
    • 性感染症（STD）の蔓延の増加
    • 避妊薬の使用を促進する政府の支援策
  • 抑制要因
    • 避妊薬の製品リコールと健康への悪影響の発生
  • 機会
    • 避妊薬の処方と包装の継続的な進歩
    • 避妊薬をオンラインチャネルを通じて利用可能
  • 課題
    • 錠剤の使用に関する安全性と社会的懸念、および製品マーケティングの問題
• 市場セグメンテーション分析
  • 製品：幅広い適用性と追加の健康上の利点により、複合ピルの採用が拡大
  • 投与経路：経口避妊薬の広範な受容、入手の容易さ、および費用対効果
  • 年齢層：15～24歳の年齢層で避妊薬の使用率が高い
  • 配信：避妊薬のオンライン配信チャネルの進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 避妊薬市場：製品別

• 配合ピル
• 継続/延長ピル
• プロゲステロンピル

第7章 避妊薬市場：年齢層別

• 15-24
• 25-34
• 35-44
• 45歳以上

第8章 避妊薬市場薬剤クラス別

• ブランド医薬品
• ジェネリック医薬品

第9章 避妊薬市場処方方法別

• オーバーザマウンター（OTC）
• 処方箋に基づく

第10章 避妊薬市場配布元

• オフライン
  • 診療所と病院
  • 薬局
  • 公衆衛生機関
• オンライン

第11章 避妊薬市場：投与経路別

• オーラル
• 膣

第12章 南北アメリカの避妊薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の避妊薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの避妊薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ペリゴは、生殖医療へのアクセスと手頃な価格の拡大を目指し、米国で初のOTCの毎日服用できる避妊薬を発売しました。
  • 英国は、ホルモンフリーの男性用避妊薬YCT-529の試験を開始し、2020年までに規制当局の承認と市場参入を目指しています。 2024
  • リヒターとミスラが、複合経口避妊薬エステルとドネスタのAPI製造供給契約を締結
  • FDA、処方箋不要の経口避妊薬を初めて承認
  • ゲデオン・リヒターが経口避妊薬ドロベリスの発売を発表
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Afaxys Pharma, LLC
• Amneal Pharmaceuticals, Inc.
• Apotex Inc.
• Aurobindo Pharma Limited
• Bayer AG
• Bionpharma Inc.
• Cipla Limited
• Combe Incorporated
• Gedeon Richter PLC
• Glenmark Pharmaceuticals Limited
• Johnson & Johnson Services, Inc.
• Julie Product Inc.
• Lupin Limited
• Mankind Pharma Ltd.
• Mayne Pharma Group Limited
• Merck & Co., Inc.
• Northstar Rx LLC
• Perrigo Company plc
• Pfizer Inc.
• Piramal Enterprises Ltd.
• Sun Pharmaceutical Industries Limited
• Syzygy Healthcare Solutions, LLC
• Teva Pharmaceuticals
• Viatris Inc.
• Xiromed, LLC

LIST OF FIGURES

• FIGURE 1. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
• FIGURE 2. CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONTRACEPTIVE PILLS MARKET DYNAMICS
• TABLE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OVER-THE-MOUNTER (OTC), BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CLINICS AND HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PUBLIC HEALTH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY VIGINAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 56. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 57. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 60. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 93. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 94. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 95. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 96. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 97. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 100. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 101. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 102. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 103. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 104. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 147. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 154. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 161. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 176. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 183. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 190. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 197. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 204. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 211. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 218. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 220. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 221. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 222. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 223. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 224. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 225. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 232. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 239. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 246. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 248. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 249. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 250. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 251. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 252. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 253. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 254. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 255. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 256. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 257. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 258. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 259. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 260. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 261. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 267. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 274. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 281. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 282. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 288. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 289. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 295. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 296. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 302. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 303. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 309. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 310. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 316. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 317. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 323. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 324. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

The Contraceptive Pills Market was valued at USD 19.53 billion in 2023, expected to reach USD 20.76 billion in 2024, and is projected to grow at a CAGR of 6.46%, to USD 30.27 billion by 2030.

The contraceptive pills market is defined by its role in preventing pregnancy through hormonal formulations that inhibit ovulation. It encompasses various types, including combined oral contraceptives (estrogen and progestin) and progestin-only pills, catering primarily to women in reproductive age groups. The necessity of contraceptive pills stems from the increasing awareness of family planning, the need for effective pregnancy prevention methods, and the empowerment of women in making reproductive choices. These pills find applications not only in contraception but also in managing menstrual disorders, acne, and endometriosis, extending their end-use scope across diverse demographics. Market growth is heavily influenced by rising educational levels, increasing access to healthcare, and growing governmental support for birth control measures. Recent advancements in lower dosage pills and the introduction of extended-cycle pills present potential opportunities for market expansion. To tap into these opportunities, companies should focus on enhancing affordability, expanding distribution channels, and raising awareness through education campaigns. However, challenges such as the perceived risk of side effects, ethical and religious opposition, and regulatory restrictions could impede market expansion. Additionally, market penetration is limited in some regions due to cultural biases and lack of awareness. Innovations in the field are ripe in the areas of developing non-hormonal pills, personalized medicine approaches, and digital health solutions for better medication adherence and tracking. These innovations, alongside strategic partnerships with healthcare providers, can drive business growth. The market exhibits a dynamic, albeit fragmented nature, indicating potential consolidation through mergers and acquisitions. Overall, staying attuned to evolving needs and perceptions, investing in R&D, and focusing on personalized experiences will be crucial for capturing growth in this competitive yet promising market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contraceptive Pills Market

The Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use of contraceptive pills to prevent unintended pregnancies and rising awareness about family planning
  • Growing prevalence of sexually transmitted diseases (STDs)
  • Supportive government initiatives to encourage use of contraceptive pills
• Market Restraints
  • Incidences of product recalls & adverse health impacts of contraceptive pills
• Market Opportunities
  • Ongoing advancements in contraceptive pill formulations and packaging
  • Availability of contraceptive pills through online channels
• Market Challenges
  • Safety and social concerns regarding pill usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contraceptive Pills Market

A detailed market share analysis in the Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contraceptive Pills Market

A strategic analysis of the Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Combination Pill, Continuous/Extended Pill, and Progesterone Pill.
• Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
• Based on Drug Class, market is studied across Branded Drugs and Generic Drugs.
• Based on Mode of Prescription, market is studied across Over-the-Mounter (OTC) and Prescription-Based.
• Based on Distribution, market is studied across Offline and Online. The Offline is further studied across Clinics and Hospitals, Pharmacies, and Public Health Organizations.
• Based on Route of Administration, market is studied across Oral and Viginal.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use of contraceptive pills to prevent unintended pregnancies and rising awareness about family planning
    • 5.1.1.2. Growing prevalence of sexually transmitted diseases (STDs)
    • 5.1.1.3. Supportive government initiatives to encourage use of contraceptive pills
  • 5.1.2. Restraints
    • 5.1.2.1. Incidences of product recalls & adverse health impacts of contraceptive pills
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in contraceptive pill formulations and packaging
    • 5.1.3.2. Availability of contraceptive pills through online channels
  • 5.1.4. Challenges
    • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging adoption of combination pills owing to their broad applicability and additional health benefits
  • 5.2.2. Route of Administration: Widespread acceptance, ease of access, and cost-effectiveness of oral contraceptives
  • 5.2.3. Age Group: High usage of contraceptive pills in the age group 15 to 24
  • 5.2.4. Distribution: Evolving online distribution channels for contraceptive pills
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Contraceptive Pills Market, by Product

• 6.1. Introduction
• 6.2. Combination Pill
• 6.3. Continuous/Extended Pill
• 6.4. Progesterone Pill

7. Contraceptive Pills Market, by Age Group

• 7.1. Introduction
• 7.2. 15-24
• 7.3. 25-34
• 7.4. 35-44
• 7.5. 45 and Above

8. Contraceptive Pills Market, by Drug Class

• 8.1. Introduction
• 8.2. Branded Drugs
• 8.3. Generic Drugs

9. Contraceptive Pills Market, by Mode of Prescription

• 9.1. Introduction
• 9.2. Over-the-Mounter (OTC)
• 9.3. Prescription-Based

10. Contraceptive Pills Market, by Distribution

• 10.1. Introduction
• 10.2. Offline
  • 10.2.1. Clinics and Hospitals
  • 10.2.2. Pharmacies
  • 10.2.3. Public Health Organizations
• 10.3. Online

11. Contraceptive Pills Market, by Route of Administration

• 11.1. Introduction
• 11.2. Oral
• 11.3. Viginal

12. Americas Contraceptive Pills Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Contraceptive Pills Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Contraceptive Pills Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Perrigo launched the First OTC daily birth control pill in the U.S., aiming to expand reproductive health access and affordability.
  • 15.3.2. UK launched trial for hormone-free male birth control YCT-529 aiming for regulatory approval and market entry by 2024
  • 15.3.3. Richter and Mithra sign supply agreement for production of API for combined oral contraceptive Estelle and Donesta
  • 15.3.4. FDA approves first nonprescription daily oral contraceptive
  • 15.3.5. Gedeon Richter announces availability of oral contraception Drovelis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Afaxys Pharma, LLC
• 3. Amneal Pharmaceuticals, Inc.
• 4. Apotex Inc.
• 5. Aurobindo Pharma Limited
• 6. Bayer AG
• 7. Bionpharma Inc.
• 8. Cipla Limited
• 9. Combe Incorporated
• 10. Gedeon Richter PLC
• 11. Glenmark Pharmaceuticals Limited
• 12. Johnson & Johnson Services, Inc.
• 13. Julie Product Inc.
• 14. Lupin Limited
• 15. Mankind Pharma Ltd.
• 16. Mayne Pharma Group Limited
• 17. Merck & Co., Inc.
• 18. Northstar Rx LLC
• 19. Perrigo Company plc
• 20. Pfizer Inc.
• 21. Piramal Enterprises Ltd.
• 22. Sun Pharmaceutical Industries Limited
• 23. Syzygy Healthcare Solutions, LLC
• 24. Teva Pharmaceuticals
• 25. Viatris Inc.
• 26. Xiromed, LLC